Morphological features of MR mammography in HER2-overexpressed breast cancer patients

被引：0
|
作者：
Artmann, A. [1 ]
Boehm, N. A. [1 ]
Laemmer-Skarke, I. [1 ]
Anneke, K. [2 ]
Harbeck, N. [2 ]
Rummeny, E. J. [1 ]
机构：
[1] Klinikum Rechts Der Isar, Sect Breast Diagnost, Munich, Germany
[2] Klinikum Rechts Der Isar, Dept Gynecol, Munich, Germany
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(10)70432-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [1] Morphological pattern of MR mammography in breast cancer patients with HER2 overexpression
    Artmann, A.
    Boehm, N. A.
    Laemmer-Skarke, I.
    Annecke, K.
    Settles, M.
    Jacobs, V. R.
    Kiechie, M.
    Rummeny, E. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Impact of adjuvant trastuzumab on locoregional recurrence in HER2-overexpressed breast cancer
    Jeon, S. H.
    Shin, K. H.
    Kim, K.
    Kim, I. A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S709 - S709
  • [3] A retrospective and prospective study of response to aromatase inhibitors and TAM in HER2-overexpressed postmenopausal breast cancer patients
    Zhang, J.
    Liu, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A phase II trial with trastuzumab and pertuzumab in patients with HER2-overexpressed locally advanced and metastatic breast cancer
    Walshe, Janice M.
    Denduluri, Neelima
    Berman, Arlene W.
    Rosing, Douglas R.
    Swain, Sandra M.
    [J]. CLINICAL BREAST CANCER, 2006, 6 (06) : 535 - 539
  • [5] Cost-Effectiveness Analysis of Trastuzumab (Herceptin) in HER2-Overexpressed Metastatic Breast Cancer
    Perez-Ellis, Carole
    Goncalves, Anthony
    Jacquemier, Jocelyne
    Marty, Michel
    Girre, Veronique
    Roche, Henri
    Brain, Etienne
    Moatti, Jean-Paul
    Viens, Patrice
    Le Corroller-Soriano, Anne-Gaelle
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05): : 492 - 498
  • [6] Absence of brain metastases in late relapse of HER2-overexpressed breast carcinoma
    Tomasevic, Z. I.
    Jovanovic, D.
    Jelic, L. Radosevic
    Tomasevic, Z. M.
    Vasovic, S.
    Stamatovic, L.
    Jelic, S.
    Spasic, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] A Review of the Management of T1a/bN0 HER2-Overexpressed Breast Cancer
    Yap, Kelly Khai Li
    Tripathy, Debu
    [J]. AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (01) : 11 - 15
  • [8] A Case Series of Patients with HER2-Overexpressed Primary Metastatic Gastroesophageal Adenocarcinoma
    Cinar, Pelin
    Calkins, Sarah M.
    Venook, Alan P.
    Kelley, Robin K.
    [J]. ANTICANCER RESEARCH, 2014, 34 (12) : 7357 - 7360
  • [9] Mechanistic insight into anti-cancer activity of plumbagin in endocrine resistant and HER2-overexpressed breast cancer cells
    Sakunrangsit, N.
    Ketchart, W.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [10] Neratinib for the treatment of early-stage, hormone receptor-positive, HER2-overexpressed breast cancer
    Jerez, Yolanda
    Herrero, Blanca
    Arregui, Marta
    Moron, Blanca
    Martin, Miguel
    Echavarria, Isabel
    [J]. FUTURE ONCOLOGY, 2020, 16 (17) : 1165 - 1177
12345